A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas

Clinical trial NCT02147158 · COMPLETED

Trial details

NCT number: NCT02147158
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Leiomyoma Uterine Hemorrhage

Start date: 2014-01-29
Primary completion: 2016-11-24
Enrollment: 432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.